Literature DB >> 10092079

TNF accelerates the onset but does not alter the incidence and severity of myelin basic protein-induced experimental autoimmune encephalomyelitis.

G Kassiotis1, M Pasparakis, G Kollias, L Probert.   

Abstract

Experimental autoimmune encephalomyelitis (EAE) induction in TNF gene-targeted mice has resulted in conflicting reports in part due to the strong association of TNF with the MHC locus. To define the participation of TNF in EAE development, we back-crossed TNF-deficient mice (H-2b) into the SJL/J strain and directly compared them to H-2b congenic SJL or inbred SJL/J mice. Induction of EAE with myelin basic protein (MBP) revealed that H-2b congenic SJL mice are fully susceptible, indicating that the H-2b haplotype does not affect disease susceptibility. Using H-2b congenic SJL mice we show here that TNF deficiency modifies the normal course of EAE by considerably delaying the onset for approximately 5 days, suggesting that TNF is required for the normal initiation of MBP-induced EAE. However, TNF-deficient mice eventually developed severe EAE with perivascular inflammation and primary demyelination similar to wild-type controls, indicating that TNF is not essential during these processes. Taken together, these results indicate that although TNF is not required for the progression of MBP-induced EAE, it contributes positively by advancing the onset of disease.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10092079     DOI: 10.1002/(SICI)1521-4141(199903)29:03<774::AID-IMMU774>3.0.CO;2-T

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  28 in total

Review 1.  Unlinking tumor necrosis factor biology from the major histocompatibility complex: lessons from human genetics and animal models.

Authors:  S R Ruuls; J D Sedgwick
Journal:  Am J Hum Genet       Date:  1999-08       Impact factor: 11.025

2.  Combination therapy with lenalidomide and nanoceria ameliorates CNS autoimmunity.

Authors:  Erez Eitan; Emmette R Hutchison; Nigel H Greig; David Tweedie; Hasan Celik; Soumita Ghosh; Kenneth W Fishbein; Richard G Spencer; Carl Y Sasaki; Paritosh Ghosh; Soumen Das; Susheela Chigurapati; James Raymick; Sumit Sarkar; Srinivasulu Chigurupati; Sudipta Seal; Mark P Mattson
Journal:  Exp Neurol       Date:  2015-08-13       Impact factor: 5.330

3.  Enhancing the ability of experimental autoimmune encephalomyelitis to serve as a more rigorous model of multiple sclerosis through refinement of the experimental design.

Authors:  Mitchell R Emerson; Ryan J Gallagher; Janet G Marquis; Steven M LeVine
Journal:  Comp Med       Date:  2009-04       Impact factor: 0.982

4.  9-Cis-retinoic acid suppresses inflammatory responses of microglia and astrocytes.

Authors:  Jihong Xu; Paul D Drew
Journal:  J Neuroimmunol       Date:  2005-11-21       Impact factor: 3.478

5.  Multimodal analysis in acute and chronic experimental autoimmune encephalomyelitis.

Authors:  Silvia Giatti; Mariaserena Boraso; Federico Abbiati; Elisa Ballarini; Donato Calabrese; Maria Santos-Galindo; Roberta Rigolio; Marzia Pesaresi; Donatella Caruso; Barbara Viviani; Guido Cavaletti; Luis Miguel Garcia-Segura; Roberto Cosimo Melcangi
Journal:  J Neuroimmune Pharmacol       Date:  2012-06-30       Impact factor: 4.147

6.  Role of tumour necrosis factor (TNF)-α and TNFRSF1A R92Q mutation in the pathogenesis of TNF receptor-associated periodic syndrome and multiple sclerosis.

Authors:  A Caminero; M Comabella; X Montalban
Journal:  Clin Exp Immunol       Date:  2011-12       Impact factor: 4.330

7.  TNF-alpha is critical for antitumor but not antiviral T cell immunity in mice.

Authors:  Thomas Calzascia; Marc Pellegrini; Håkan Hall; Laurent Sabbagh; Nobuyuki Ono; Alisha R Elford; Tak W Mak; Pamela S Ohashi
Journal:  J Clin Invest       Date:  2007-12       Impact factor: 14.808

8.  Regulation of proinflammatory cytokine expression in primary mouse astrocytes by coronavirus infection.

Authors:  Dongdong Yu; Hongqing Zhu; Yin Liu; Jianzhong Cao; Xuming Zhang
Journal:  J Virol       Date:  2009-09-23       Impact factor: 5.103

9.  Interleukin-25 expressed by brain capillary endothelial cells maintains blood-brain barrier function in a protein kinase Cepsilon-dependent manner.

Authors:  Yoshifumi Sonobe; Hideyuki Takeuchi; Kunio Kataoka; Hua Li; Shijie Jin; Maya Mimuro; Yoshio Hashizume; Yasuteru Sano; Takashi Kanda; Tetsuya Mizuno; Akio Suzumura
Journal:  J Biol Chem       Date:  2009-09-23       Impact factor: 5.157

10.  Unmasking of a protective tumor necrosis factor receptor I-mediated signal in the collagen-induced arthritis model.

Authors:  Cheryll Williams-Skipp; Thiagarajan Raman; Robert J Valuck; Herschel Watkins; Brent E Palmer; Robert I Scheinman
Journal:  Arthritis Rheum       Date:  2009-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.